Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Allakos Inc.    ALLK

ALLAKOS INC.

(ALLK)
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Allakos Inc.
Allakos, Inc. is a clinical-stage biotechnology company, which is engaged in developing antibodies that selectively target mast cells and eosinophils. The Company's antibodies target receptor molecules present on the surface of immune effector cells, which are involved in allergy, inflammation and tissue damage. Its lead program is AK002, which is an antibody that targets Siglec-8, an inhibitory receptor found on eosinophils and mast cells. The Company's AK002 is used in the treatment of various diseases with abnormal proliferation of mast cells, including eosinophilic gastritis (EG), indolent systemic mastocytosis, urticaria and allergic conjunctivitis.

Number of employees : 62 people.
Managers
NameAgeSinceTitle
Robert Alexander, Dr.482019Chief Executive Officer & Director
Adam L. Tomasi, Dr.482019President & Chief Operating Officer
Dan S. Janney522017Chairman
Leo J. Redmond-2019Chief Financial & Accounting Officer
Henrik Sandvad Rasmussen, Dr.592017Chief Medical Officer
John P. McKearn, Dr.642012Independent Director
Steven P. James592016Independent Director
Paul E. Walker432017Independent Director
Robert E. Andreatta562018Independent Director
Simon Greenwood, Dr.-2016Chief Business Officer
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 48,664,000 43,701,751 89.8% 0 0.0% 89.8%
Shareholders
NameEquities%
Alta Partners Management Corp. 11,519,200 23.8%
RiverVest Venture Management LLC 6,900,506 14.3%
Capital Research & Management Co. (Global Investors) 5,059,493 10.5%
Bayer Aktiengesellschaft 4,610,723 9.52%
NEA Management Co. LLC 4,536,376 9.37%
Capital Research & Management Co. (World Investors) 3,494,852 7.22%
Capital Research & Management Co. (International Investors) 3,408,807 7.04%
Fidelity Management & Research Co. 3,289,839 6.80%
Redmile Group LLC 3,077,128 6.36%
The Vanguard Group, Inc. 2,312,061 4.78%
Company contact information
Allakos, Inc.
975 Island Drive
Suite 201
Redwood, CA 94070

Phone : +1.650.597.5002
Web : http://www.allakos.com